Contrast-enhanced breast computed tomography: can lymph node metastasis be predicted from primary tumor?

Vedantham, Srinivasan

doi:10.1007/s00330-023-10399-4

Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.

Eur Radiol

2023

DOI: 10.1007/s00330-023-10399-4

|View full text |Cite

Contrast-enhanced breast computed tomography: can lymph node metastasis be predicted from primary tumor?

Srinivasan Vedantham

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 10 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Emerging Clinical Applications for Cone Beam Breast CT: Changing the Breast Imaging Paradigm

Siddall,

Zhang,

O’Connell

2024

Curr Breast Cancer Rep

View full text Add to dashboard Cite

Purpose of Review Since its approval by the Unites States Food and Drug Administration (FDA) in 2015, cone-beam breast computed tomography (CBBCT) has gained acceptance among radiologists for breast cancer imaging. This review aims to highlight the advancements and benefits of CBBCT in the diagnostic workup of breast disease. It showcases how CBBCT, including both non-contrast (NC-CBBCT) and contrast-enhanced (CE-CBBCT) protocols, complements and often surpasses the performance of more traditional breast imaging modalities such as mammography and magnetic resonance imaging (MRI). Recent Findings Studies in clinical settings have shown CBBCT’s efficacy in detecting and characterizing breast lesions of differing morphologies, including non-mass enhancement and calcifications—tasks that previously required the use of multiple modalities. In addition, CBBCT significantly enhances patient comfort and efficiency, offering quick acquisition times without the discomfort of breast compression. The technology can be utilized for guiding biopsies, planning surgical interventions, and assessing breast density and tumor characteristics, evidence supporting its integration into clinical practice. Summary CBBCT holds the potential to shift the imaging paradigm in breast cancer care, indicating a promising future for the modality in terms of enhancing diagnostic accuracy, improving patient experience, and influencing treatment outcomes.

show abstract

Emerging Clinical Applications for Cone Beam Breast CT: Changing the Breast Imaging Paradigm

Siddall,

Zhang,

O’Connell

2024

Curr Breast Cancer Rep

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

hi@scite.ai

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Contrast-enhanced breast computed tomography: can lymph node metastasis be predicted from primary tumor?

Cited by 1 publication

References 10 publications

Emerging Clinical Applications for Cone Beam Breast CT: Changing the Breast Imaging Paradigm

Emerging Clinical Applications for Cone Beam Breast CT: Changing the Breast Imaging Paradigm

Contact Info

Product

Resources

About